Nick Borgia

Nick Borgia currently serves as Sr. Director for the National Accounts Team at Biocon Biologics, leading initiatives to enhance market share and revenue growth. Previously, Borgia held various leadership positions at Viatris, Melinta Therapeutics, DePuy Synthes Companies, Alkermes, and Ferring Pharmaceuticals, focusing on pricing, contracting, and market access strategies across healthcare systems. Borgia has successfully managed teams and developed strategic initiatives that resulted in substantial increases in patient engagement and revenue generation. Educational credentials include a BA in Psychology from Coker University.